DALLAS — Susan G. Komen for the Cure announced Monday that a physician with a long career in health policy and research will become the breast cancer charity's new president and CEO.
Judith A. Salerno will replace Nancy Brinker as CEO of the Dallas-based organization. Brinker, whose promise to her dying sister begat a fundraising powerhouse that has invested hundreds of millions of dollars in cancer research, announced last summer she would step down following an onslaught of criticism over Komen's decision — quickly reversed — to stop giving grants to Planned Parenthood for breast cancer screenings.
Salerno, 61, is executive director and chief operating officer of the Institute of Medicine of the National Academy of Sciences, a prestigious independent group that advises the government and private sector about health and science.
"Komen's commitment has helped countless numbers of low-income and medically underserved women and men get care they might otherwise have gone without, and Komen's research program is one of the most highly respected in the nation," Salerno said in a statement.
The appointment of Salerno, with her deep medical background, comes after the embattled Komen foundation saw several executives leave and numbers fall at their fundraising Races for the Cure across the country in the months after the Planned Parenthood controversy. Earlier this month, Komen announced it was canceling half of its three-day charity walks due to a drop in participation levels.
When asked about Salerno's views on Planned Parenthood or the funding controversy, Komen spokeswoman Andrea Rader said the charity was focusing on moving forward.
"That's an issue that was settled a long time ago," Rader said, also describing Salerno as a good fit due to her experience in a range of areas, from public policy to community health.
Leaders of Komen affiliates met Monday's announcement with enthusiasm.